Announcement on the guidelines for stability research of passive implantable medical devices

Date of issue:

2022-03-16

Views:

In order to further strengthen the management of the stability research of passive implantable medical devices, the Device Audit Center of the State Food and Drug Administration organized and formulated the Guiding Principles for the Stability Research of Passive Implantable Medical Devices (Revised in 2022), which is hereby issued.


It is hereby notified.


Annex: Guidelines for stability study of passive implantable medical devices (revised in 2022) 


State Drug Administration


Medical Device Technical Evaluation Center

March 15, 2022




Source: National Drug Administration Medical Device Technical Evaluation Center

Recommend

Notice on Organizing the Work of Launching the Innovation Task of Biomedical Materials
All provinces, autonomous regi...
Wuhan Asia Biological was approved as a medical device for artificial bone repair
On November 14, the State Food...
Notice of the Device Audit Center of the State Food and Drug Administration (No. 39, 2022)
In order to further standardiz...
Q1-1 Biomaterials for bone regeneration
Inanimate biomaterials can ind...